Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | FEIBA 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials (Takeda UK Ltd) |
| Virtual Medicinal Product | Factor VIII Inhibitor Bypassing Fraction human 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials |
| Name | FEIBA 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials |
| Abbreviated name | FEIBA 25units/ml (500unit) pdr and 20ml solvent inf vials |
| Date of name applicability | 17 Feb 2021 |
| Previous name | FEIBA 500unit powder and solvent for solution for injection vials |
| Supplier | Takeda UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| FEIBA 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials (Takeda UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.